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ABSTRACT
Summary: We created a fast, robust and general C++ implementa-
tion of a single-nucleotide polymorphism (SNP) set enrichment algo-
rithm to identify cell types, tissues and pathways affected by risk loci.
It tests trait-associated genomic loci for enrichment of specificity to
conditions (cell types, tissues and pathways). We use a non-paramet-
ric statistical approach to compute empirical P-values by comparison
with null SNP sets. As a proof of concept, we present novel applica-
tions of our method to four sets of genome-wide significant SNPs
associated with red blood cell count, multiple sclerosis, celiac disease
and HDL cholesterol.
Availability and implementation: http://broadinstitute.org/mpg/
snpsea
Contact: soumya@broadinstitute.org
Supplementary information: Supplementary data are available at
Bioinformatics online.
Received on December 12, 2013; revised on April 3, 2014; accepted
on May 5, 2014
1I N T R O D U C T I O N
As genome-wide association studies (GWAS) continue to find
disease alleles, investigators seek to identify the set of pathways
and tissue types affected by these alleles, and the physiological
conditions under which they act (Elbers et al., 2009; Lango Allen
et al., 2010; Raychaudhuri, 2011; Wang et al., 2013; Yaspan and
Veatch, 2011). For example, we have previously presented
statistical methods to identify immune cell types for further func-
tional investigation by finding cell type-specific expression of
genes in linkage disequilibrium (LD) with autoimmune disease-
associated single-nucleotide polymorphisms (SNPs) (Hu et al.,
2011). Presumably, alleles influence disease risk through path-
ways specific to these cell types.
We sought a general implementation of these methods to
leverage data from high-throughput functional assays that
assess genome-wide transcription, protein binding, epigenetic
modifications and other functional parameters across diverse
cellular conditions and tissue types. Each of these diverse data
types can be represented as a continuous matrix of genes
and conditions (e.g. cell types, tissues, pathways, experimental
conditions). Databases such as Gene Ontology (GO) (Botstein
et al., 2000) offer expert-defined pathways and complementary
gene annotations that can be represented as binary values.
Investigators have already described strategies to assess enrich-
ment of GWA results for pathways or gene sets but not for
condition specificity (Holden et al., 2008; Weng et al., 2011).
In contrast to these methods, we do not require genotypes,
P-values, a priori gene sets or pathways or ap r i o r idefinitions
of gene–SNP associations. We require only a list of SNP identi-
fiers, use LD structures to identify plausibly influential genes and
use a simple sampling approach to identify the conditions they
influence.
SNPsea is a general algorithm to identify the conditions rele-
vant to a trait by assessing the genes within associated loci for
enrichment of condition specificity.
2 METHODS
For a given set of SNPs, SNPsea tests genes implicated by LD, in aggre-
gate, for enrichment of specificity to a condition in a given matrix of
genes and conditions. The matrix must be normalized so that conditions
are comparable.
First, we identify genes implicated by each SNP using LD from refer-
ence genomes. Second, we calculate a specificity score for each condition
with these genes. Finally, we compare these scores with scores obtained
with null sets of matched SNP sets to calculate an empirical P-value for
each condition (see Supplementary Notes for algorithm details).
We empirically calculate P-values because we previously found that
analytical distributions can result in inaccurate P-values (Hu et al., 2011).
SNP linkage intervals, gene densities, gene sizes and gene functions are
correlated across the genome and are challenging to model analytically.
We used C++ for fast computation of P-values because Python was
prohibitively slow. The online reference manual details compilation and
installation procedures; we also provide executable files for immediate use
on select platforms.
2.1 Multiple genes implicated by LD
Accurate analyses must address the critical issue that SNPs from GWA
studies frequently implicate more than one gene (50% of GWAS Catalog
SNPs, Supplementary Fig. S2).
We defined LD intervals with SNPs from the 1000 Genomes Project
(EUR) (Genomes Project Consortium, 2010) and a previously described
strategy (Supplementary Fig. S1) (Rossin et al., 2011). A SNP implicates
genes overlapping its LD interval, defined by the furthest SNPs in a 1Mb
window with r
240.5. To ensure the associated genes are included, we
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merge SNPs with shared genes into a single locus.
By default, we assume that each associated locus harbours a single
influential gene rather than multiple genes. We provide an alternative
scoring method to account for multiple genes (Supplementary Notes)
that produces similar results in four traits we tested (Supplementary
Fig. S4).
Because interval lengths depend on the choice of r
2 threshold, we
looked for an effect of this choice (Supplementary Fig. S3). The signifi-
cant result for the Gene Atlas and blood cell count SNPs is robust to
different thresholds. Similarly, the choice of r
2 threshold has little effect
on the significant GO enrichment result for these SNPs.
2.2 Type I error estimates
We tested 10000 sets of 100 randomly selected LD-pruned SNPs. For
each condition (tissue or GO term), we observed appropriate proportions
of P-values50.5, 0.1, 0.05, 0.01 and 0.005 (Supplementary Fig. S5).
3E X A M P L E S
We used SNPsea to identify tissues relevant to blood cell count
by testing 45 genome-wide significant SNPs (van der Harst et al.,
2012) with expression data (Gene Atlas) for 17581 genes across
79 human tissues (Su et al., 2004). Bone marrow CD71+early
erythroid cells are significantly enriched for cell type-specific
expression of the genes within the trait-associated loci
(P=210
–7) (Fig. 1).
The genes in these loci are enriched for the term hemopoiesis
(GO:0030097) (P=210
–5) (Supplementary Fig. S6), suggest-
ing that blood cell count may be influenced by the genes ex-
pressed specifically in early erythroid cells and involved in
forming blood cellular components.
We provide additional examples for SNPs associated with
multiple sclerosis, celiac disease and HDL cholesterol. Each in-
cludes Gene Atlas and GO enrichments, r
2 comparisons and
comparisons of results assuming a single or multiple causal
genes (Supplementary Figs S7–9).
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Fig. 1. Empirical P-values for specificity to each condition. 25 of 79
tissues (Gene Atlas) are shown. Adjacent: Pearson correlation coefficients
for pairs of expression profiles ordered by hierarchical clustering with
UPGMA
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